Serum analysis revealed that BUN, creatinine, uric acid, serum cystatin C, and neutrophil gelatinase associated lipocalin (NGAL) levels were found to be lowered in BA-treated rats compared to control CKD groups. Here, LCN2 is linked to chronic kidney disease.